Abstract

ObjectiveThe present study aims to explore potential infection and death risk factors in patients infected with carbapenem-resistant Klebsiella pneumoniae (CRKP).MethodsA retrospective case-control study was performed at Beijing Shijitan Hospital, China. The clinical and microbiological data of patients infected with K. pneumoniae (K.pn) were collected; the clinical characteristics of patients infected with carbapenem-susceptible K.pn and CRKP were analyzed using logistic regression analysis.ResultsCRKP infection was significantly associated with prior carbapenem use (odds ratio [OR] and 95% credibility interval [CI]: 5.161 [1.840–32.233], P < 0.001), the use of more than three types of antibiotics for seven or more days (OR and 95% CI: 9.681 [2.662–18.122], P < 0.001), tracheotomy (OR and 95% CI: 5.015 [2.343–11.724], P < 0.001), and intensive care unit (ICU) stay (OR and 95% CI: 6.322 [2.02–12.231], P < 0.001). The risk of death in patients with CRKP infection was significantly associated with older age (OR and 95% CI of 70–80 years: 8.894 [1.972–67.346], P < 0.001; ≥80 years: 15.234 [2.072–93.452], P < 0.001), renal dysfunction (OR and 95% CI: 1.672 [1.104–7.451], P = 0.016), tracheotomy (OR and 95% CI: 2.051 [1.217–11.235], P = 0.002), and ICU stay (OR and 95% CI: 3.043 [2.174–18.453], P < 0.001).ConclusionPrior to carbapenem use, older age, renal dysfunction, tracheotomy, and ICU stay were independent risk factors for death in patients infected with CRKP.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.